CRISPR Therapeutics
Gene-based medicines for patients with serious diseases. Learn more
Launch date
Employees
Market cap
$4.2b
Enterprise valuation
$3.9b (Public information from Sep 2024)
Share price
$49.49 CRSP
Company register number CH-270.3.014.931-8
Basel Canton of Basel-Stadt (HQ)
Authorizing premium user...